Eric Ormsby

1.1k total citations
18 papers, 341 citations indexed

About

Eric Ormsby is a scholar working on Immunology, Statistics and Probability and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Eric Ormsby has authored 18 papers receiving a total of 341 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Immunology, 5 papers in Statistics and Probability and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Eric Ormsby's work include Biosimilars and Bioanalytical Methods (6 papers), Statistical Methods in Clinical Trials (5 papers) and Hearing, Cochlea, Tinnitus, Genetics (4 papers). Eric Ormsby is often cited by papers focused on Biosimilars and Bioanalytical Methods (6 papers), Statistical Methods in Clinical Trials (5 papers) and Hearing, Cochlea, Tinnitus, Genetics (4 papers). Eric Ormsby collaborates with scholars based in Canada, United States and Netherlands. Eric Ormsby's co-authors include K. Karpinski, E.A. Nera, E. Lok, David B. Clayson, F. Iverson, Aaron Bayne, E. M. Hawes, G. McKay, R. C. Lawrence and Mario L. Rocci and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, International Journal of Pharmaceutics and Pharmaceutical Research.

In The Last Decade

Eric Ormsby

17 papers receiving 290 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eric Ormsby Canada	12	79	65	62	44	38	18	341
Steven Foster United States	11	48 0.6×	68 1.0×	133 2.1×	19 0.4×	25 0.7×	39	606
Eberhard Scheuch Germany	13	26 0.3×	90 1.4×	88 1.4×	25 0.6×	43 1.1×	36	461
Xiaofeng Zhao China	12	41 0.5×	48 0.7×	119 1.9×	24 0.5×	31 0.8×	48	428
Francesca Canalías Spain	10	26 0.3×	43 0.7×	96 1.5×	24 0.5×	31 0.8×	49	522
Joel Sequeira United States	9	36 0.5×	34 0.5×	31 0.5×	60 1.4×	37 1.0×	15	408
Ryosuke Sato Japan	8	54 0.7×	46 0.7×	138 2.2×	53 1.2×	17 0.4×	27	477
Joseph P. Chamberlain United Kingdom	14	26 0.3×	123 1.9×	94 1.5×	48 1.1×	28 0.7×	42	583
Charles Bon United States	10	40 0.5×	57 0.9×	53 0.9×	10 0.2×	38 1.0×	24	471
Oscar E. Araujo United States	10	35 0.4×	147 2.3×	83 1.3×	33 0.8×	19 0.5×	28	518
Engy Shokry Germany	14	35 0.4×	43 0.7×	139 2.2×	25 0.6×	118 3.1×	38	486

Countries citing papers authored by Eric Ormsby

Since Specialization

Citations

This map shows the geographic impact of Eric Ormsby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Ormsby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Ormsby more than expected).

Fields of papers citing papers by Eric Ormsby

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric Ormsby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Ormsby. The network helps show where Eric Ormsby may publish in the future.

Co-authorship network of co-authors of Eric Ormsby

This figure shows the co-authorship network connecting the top 25 collaborators of Eric Ormsby. A scholar is included among the top collaborators of Eric Ormsby based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric Ormsby. Eric Ormsby is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Chen, Mei‐Ling, Vinod P. Shah, Daan J.A. Crommelin, et al.. (2011). Harmonization of Regulatory Approaches for Evaluating Therapeutic Equivalence and Interchangeability of Multisource Drug Products: Workshop Summary Report. The AAPS Journal. 13(4). 556–564. 13 indexed citations

Chen, Mei‐Ling, Vinod P. Shah, Daan J.A. Crommelin, et al.. (2011). Harmonization of Regulatory Approaches for Evaluating Therapeutic Equivalence and Interchangeability of Multisource Drug Products: Workshop summary report. European Journal of Pharmaceutical Sciences. 44(4). 506–513. 18 indexed citations

Savoie, Natasha, Fabio Garofolo, Peter van Amsterdam, et al.. (2009). 2009 White Paper on Recent Issues in Regulated Bioanalysis from The 3rd Calibration and Validation Group Workshop. Bioanalysis. 2(1). 53–68. 37 indexed citations

Savoie, Natasha, Brian Booth, Fabio Garofolo, et al.. (2009). The 2nd Calibration and Validation Group Workshop on Recent Issues in Good Laboratory Practice Bioanalysis. Bioanalysis. 1(1). 19–30. 40 indexed citations

Cyr, Terry D., et al.. (1997). Metered dose inhalers III: metaproterenol sulphate; particle size distribution and dose uniformity. Journal of Pharmaceutical and Biomedical Analysis. 15(11). 1709–1718. 5 indexed citations

LeBelle, Michael J., et al.. (1997). Metered-dose inhalers. II. Particle size measurement variation. International Journal of Pharmaceutics. 151(2). 209–221. 5 indexed citations

LeBelle, Michael J., et al.. (1996). Metered-dose inhalers I: drug content and particle size distribution of beclomethasone dipropionate. Journal of Pharmaceutical and Biomedical Analysis. 14(7). 793–800. 16 indexed citations

Lawrence, R. C., et al.. (1995). Particle Size Distribution of Single and Multiple Sprays of Salbutamol Metered-Dose Inhalers (MDIs). Pharmaceutical Research. 12(9). 1380–1384. 13 indexed citations

Karpinski, K., et al.. (1995). Toxicodynamics and toxicokinetics of amikacin in the guinea pig cochlea. Hearing Research. 83(1-2). 62–79. 11 indexed citations

10.

Sahai, Jan, Keith Gallicano, Eric Ormsby, Gary Garber, & D. William Cameron. (1994). Relationship between body weight, body surface area and serum zidovudine pharmacokinetic parameters in adult, male HIV-infected patients. AIDS. 8(6). 793–796. 8 indexed citations

11.

Midha, K.K., et al.. (1993). Logarithmic Transformation in Bioequivalence: Application with Two Formulations of Perphenazine. Journal of Pharmaceutical Sciences. 82(2). 138–144. 32 indexed citations

12.

Gallicano, Keith, et al.. (1993). Pharmacokinetics of zidovudine after the initial single dose and during chronic‐dose therapy in HIV‐infected patients.. British Journal of Clinical Pharmacology. 36(2). 128–131. 11 indexed citations

13.

Foster, Brian C., et al.. (1992). In vitro assessment of cytotoxicity and biotransformation of propranolol in Cunninghamella echinulata. Xenobiotica. 22(11). 1221–1228. 4 indexed citations

14.

Ormsby, Eric, et al.. (1991). Harmonization of bioavailability and bioequivalence requirements.. PubMed. Spec No 3. 533–40.

15.

Ormsby, Eric, et al.. (1991). Evidence that amikacin ototoxicity is related to total perilymph area under the concentration-time curve regardless of concentration. Antimicrobial Agents and Chemotherapy. 35(6). 1070–1074. 29 indexed citations

16.

Desjardins, Suzanne, et al.. (1990). Delay in Hearing Loss Following Drug Administration. Acta Oto-Laryngologica. 109(5-6). 345–352. 16 indexed citations

17.

Desjardins, Suzanne, et al.. (1989). Incidence of amikacin ototoxicity: A sigmoid function of total drug exposure independent of plasma levels. American Journal of Otolaryngology. 10(4). 234–243. 24 indexed citations

18.

Nera, E.A., E. Lok, F. Iverson, et al.. (1984). Short-term pathological and proliferative effects of butylated hydroxyanisole and other phenolic anti-oxidants in the forestomach of Fischer 344 rats. Toxicology. 32(3). 197–213. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact